Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine

Vaccine

Volumn 27, Issue 12, 2009, Pages 1869-1874

  Zhang, Jun ^a   Liu, Chong bo ^b   Li, Rong cheng ^c   Li, Yi min ^d   Zheng, Ying jie ^e   Li, Yan ping ^c   Luo, Dong ^c   Pan, Bai bin ^c   Nong, Yi ^c   Ge, Sheng Xiang ^a   Xiong, Jun hui ^a   Shih, James Wai kuo ^a   Ng, Mun Hon ^a   Xia, Ning shao ^a  

^a XIAMEN UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c GUANGXI CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d Beijing Wantai Biol Pharm E   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

Clinical trial; Hepatitis E; HEV; HEV vaccine

Indexed keywords

HEPATITIS B VACCINE; HEPATITIS E ANTIBODY; HEPATITIS E VACCINE; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT HEPATITIS E VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG DOSE REGIMEN; DRUG SAFETY; ENDEMIC DISEASE; HEPATITIS E; HIGH SCHOOL STUDENT; HUMAN; IMMUNOGENICITY; INFECTION; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHINA; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENDEMIC DISEASES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; REFERENCE STANDARDS; TREATMENT OUTCOME; VACCINES, SYNTHETIC; VIRAL VACCINES; YOUNG ADULT;

EID: 61349155443     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.12.061     Document Type: Article

References (26)

1. Reyes G.R., Purdy M.A., Kim J.P., Luk K.C., Young L.M., Fry K.E., et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247 Mar 4948 (1990) 1335-1339
2. Schlauder G.G., and Mushahwar I.K. Genetic heterogeneity of hepatitis E virus. J Med Virol 65 Oct 2 (2001) 282-292
3. Lu L., Li C., and Hagedorn C.H. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 16 Jan-Feb 1 (2006) 5-36
4. Khuroo M.S. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 68 Jun 6 (1980) 818-824
5. Viswanathan R. Epidemiology. Indian J Med Res 45 Jan Suppl. (1957) 1-29
6. Kar P., Jilani N., Husain S.A., Pasha S.T., Anand R., Rai A., et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy?. Am J Gastroenterol 103 Oct 10 (2008) 2495-2501
7. Khuroo M.S., and Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 10 Jan 1 (2003) 61-69
8. Zheng Y., Ge S., Zhang J., Guo Q., Ng M.H., Wang F., et al. Swine as a principal reservoir of hepatitis E virus that infects humans in eastern China. J Infect Dis 193 Jun 12 (2006) 1643-1649
9. Hsieh S.Y., Meng X.J., Wu Y.H., Liu S.T., Tam A.W., Lin D.Y., et al. Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus. J Clin Microbiol 37 Dec 12 (1999) 3828-3834
10. Chau T.N., Lai S.T., Tse C., Ng T.K., Leung V.K., Lim W., et al. Epidemiology and clinical features of sporadic hepatitis E as compared with hepatitis A. Am J Gastroenterol 101 Feb 2 (2006) 292-296
11. Meng X.J., Purcell R.H., Halbur P.G., Lehman J.R., Webb D.M., Tsareva T.S., et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 94 Sep 18 (1997) 9860-9865
12. van der Poel W.H., Verschoor F., van der Heide R., Herrera M.I., Vivo A., Kooreman M., et al. Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands. Emerg Infect Dis 7 Nov-Dec 6 (2001) 970-976
13. Takahashi K., Kitajima N., Abe N., and Mishiro S. Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology 330 Dec 2 (2004) 501-505
14. Martelli F., Caprioli A., Zengarini M., Marata A., Fiegna C., Di Bartolo I., et al. Detection of hepatitis E virus (HEV) in a demographic managed wild boar (Sus scrofa scrofa) population in Italy. Vet Microbiol 126 Jan 1-3 (2008) 74-81
15. Tei S., Kitajima N., Takahashi K., and Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 362 Aug 9381 (2003) 371-373
16. Li T.C., Chijiwa K., Sera N., Ishibashi T., Etoh Y., Shinohara Y., et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 11 Dec 12 (2005) 1958-1960
17. Dalton H.R., Stableforth W., Hazeldine S., Thurairajah P., Ramnarace R., Warshow U., et al. Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A. Eur J Clin Microbiol Infect Dis 27 Jul 7 (2008) 579-585
18. Zhang M., Emerson S.U., Nguyen H., Engle R.E., Govindarajan S., Gerin J.L., et al. Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine 20 Dec 5-6 (2001) 853-857
19. Shrestha M.P., Scott R.M., Joshi D.M., Mammen Jr. M.P., Thapa G.B., Thapa N., et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 356 Mar 9 (2007) 895-903
20. Li S.W., Zhang J., Li Y.M., Ou S.H., Huang G.Y., He Z.Q., et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 23 Apr 22 (2005) 2893-2901
21. Zhang J.Z., Ng M.H., Xia N.S., Lau S.H., Che X.Y., Chau T.N., et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol 64 Jun 2 (2001) 125-132
22. Li S.W., Zhang J., He Z.Q., Gu Y., Liu R.S., Lin J., et al. Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem 280 Feb 5 (2005) 3400-3406
23. Zhang J., Gu Y., Ge S.X., Li S.W., He Z.Q., Huang G.Y., et al. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 23 Apr 22 (2005) 2881-2892
24. Wu T., Wu X.L., Ou S.H., Lin C.X., Cheng T., Li S.W., et al. Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity. Mol Immunol 44 May 12 (2007) 3261-3266
25. Ge S., Zhang J., Huang G., Pang S., Zhou K., and Xia N. The immuno-protect study of a hepatitis E virus ORF2 peptide expressed in E. coli. Wei Sheng Wu Xue Bao 43 Feb 1 (2003) 35-42
26. Li R.C., Ge S.X., Li Y.P., Zheng Y.J., Nong Y., Guo Q.S., et al. Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis 12 Nov 11 (2006) 1682-1688